
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 16.05.2026
Psychemedics Corporation Betriebszyklus 2011-2026 | PMD
Betriebszyklus Jährlich Psychemedics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.4 | 61.3 | 56.8 | 54.7 | 61 | 36.6 | 41.3 | 41.3 | 54.7 | 59.3 | 73.7 | 66.9 | 79.2 | 76.6 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 79.2 | 36.6 | 58.6 |
Betriebszyklus Vierteljährlich Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.3 | 67 | 64.5 | - | 68.8 | 66.4 | 60.7 | - | 65.5 | 63.8 | 61.8 | - | 59.2 | 59.9 | 58.9 | 57.4 | 59.2 | 92.4 | 43.2 | 39.6 | 35 | 37.1 | 40 | 44.4 | 40 | 40.9 | 38.9 | 42 | 40.8 | 42.3 | 46.1 | - | - | - | - | - | - | - | - | 55 | 48.3 | 48.4 | 54.7 | 61.5 | 56.5 | 57.8 | 63.8 | 74.5 | 65.3 | 61.5 | 66.6 | 73.9 | 64.9 | 65.8 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 92.4 | 35 | 56.1 |
Betriebszyklus anderer Aktien in der Diagnostik & Forschung
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 5.14 | -10.76 % | $ 6.84 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 19.15 | -1.82 % | $ 589 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 21.36 | -1.13 % | $ 619 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
128 | $ 127.58 | -4.12 % | $ 16 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
Illumina
ILMN
|
204 | $ 162.64 | -3.23 % | $ 25.2 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.39 | -3.16 % | $ 1.19 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 149.96 | -1.86 % | $ 11.8 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 102.59 | -0.22 % | $ 6.92 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
102 | $ 10.96 | -3.14 % | $ 1.4 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 183.85 | -1.06 % | $ 9.11 B | ||
|
Natera
NTRA
|
48.3 | $ 218.2 | -1.76 % | $ 29.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
244 | $ 1.46 | -10.74 % | $ 438 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 455.55 | -0.68 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 155.01 | -2.16 % | $ 23.8 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.64 | -0.96 % | $ 430 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.52 | -1.14 % | $ 437 M | ||
|
Personalis
PSNL
|
63.8 | $ 11.02 | -8.93 % | $ 983 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.17 | 0.67 % | $ 24.8 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.7 | -4.49 % | $ 280 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
204 | $ 2.21 | 2.79 % | $ 5.08 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 265.31 | 1.61 % | $ 22.1 B | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 69.92 | -5.43 % | $ 4.18 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 474.37 | -1.6 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.72 | 5.2 % | $ 259 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
834 | $ 366.13 | -2.74 % | $ 21.8 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 8.99 | -1.48 % | $ 1.95 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 200.67 | 2.3 % | $ 22.3 B |